A new approach to treating endometrial cancer patients not only stops the growth of tumors, but also kills the cancer cells. In a potentially major breakthrough, scientists discovered that introducing a particular inhibitor drug can turn “off” receptors responsible for the growth of tumors in a significant number of patients with endometrial cancer.